The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis

Published:2017-04-07 Issue:1 Volume:18 Page:
ISSN:1129-2369
Container-title:The Journal of Headache and Pain
language:en
Short-container-title:J Headache Pain

Author:

Hou Min,Xing Haiyan,Cai Yongqing,Li Bin,Wang Xianfeng,Li Pan,Hu Xiaolin,Chen Jianhong

Funder

the National Natural Science Foundation of China

Research project of Chongqing Science and Technology

research project of Third Military Medical University

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Link

http://link.springer.com/article/10.1186/s10194-017-0750-1/fulltext.html

Reference62 articles.

1. Edvinsson L (2008) CGRP blockers in migraine therapy: where do they act? Br J Pharmacol 155:967–969

2. Tfelthansen P (2012) Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update. Curr Clin Pharmacol 7:66–72

3. David Dodick MD, Lipton RB, Vincent Martin MD, Vasilios Papademetriou MD, Rosamond W, Maassenvandenbrink A, Hassan Loutfi MD, Welch KM, PhD PJGM, Steven Hahn MD (2004) Consensus statement: cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine. Headache 44:414–425

4. Fozard JR, Kalkman HO (1994) 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn Schmiedeberg’s Arch Pharmacol 350:225–229

5. Silberstei SD (2005) Serotonin (5‐HT) and Migraine. Headache 34:408–417

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of atogepant, a small molecule CGRP receptor antagonist, for the preventive treatment of migraine: a systematic review and meta-analysis;The Journal of Headache and Pain;2024-07-19

2. Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review;BMJ Neurology Open;2024-04

3. Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis;Clinical Psychopharmacology and Neuroscience;2023-11-08

4. Adverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database;Expert Opinion on Drug Safety;2023-09-18

5. Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache;Cephalalgia;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3